Exane Derivatives’s ZYNGA INC. CL A COMMON ZNGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,065
Closed -$46.8K 1064
2022
Q1
$46.8K Buy
+5,065
New +$44.5K 0.01% 575
2021
Q4
Sell
-6,296
Closed -$47.4K 1114
2021
Q3
$47.4K Sell
6,296
-7,155
-53% -$65K 0.01% 619
2021
Q2
$143K Sell
13,451
-161
-1% -$1.7K 0.03% 493
2021
Q1
$139K Sell
13,612
-31,956
-70% -$334K 0.04% 349
2020
Q4
$450K Sell
45,568
-189
-0.4% -$1.7K 0.13% 183
2020
Q3
$417K Sell
45,757
-7,046
-13% -$65.5K 0.12% 152
2020
Q2
$504K Buy
+52,803
New +$433K 0.13% 128
2019
Q2
Sell
-1
Closed -$5 743
2019
Q1
$5 Sell
1
-12,783
-100% -$61.4K ﹤0.01% 630
2018
Q4
$50.2K Hold
12,784
0.01% 361
2018
Q3
$51.8K Buy
12,784
+11,593
+973% +$46.7K 0.01% 369
2018
Q2
$4.82K Sell
1,191
-2,823
-70% -$11.1K ﹤0.01% 472
2018
Q1
$14.7K Buy
4,014
+3,136
+357% +$11.6K ﹤0.01% 404
2017
Q4
$3.51K Buy
878
+602
+218% +$2.35K ﹤0.01% 441
2017
Q3
$1.04K Buy
276
+197
+249% +$726 ﹤0.01% 455
2017
Q2
$288 Sell
79
-1,700
-96% -$5.58K ﹤0.01% 518
2017
Q1
$5.07K Sell
1,779
-1,686
-49% -$4.53K ﹤0.01% 374
2016
Q4
$8.9K Sell
3,465
-281
-8% -$793 ﹤0.01% 403
2016
Q3
$10.9K Sell
3,746
-29
-0.8% -$81 ﹤0.01% 394
2016
Q2
$9.4K Buy
+3,775
New +$9.42K ﹤0.01% 372
2015
Q3
Sell
-11,422
Closed -$32.7K 576
2015
Q2
$32.7K Hold
11,422
﹤0.01% 313
2015
Q1
$32.6K Hold
11,422
﹤0.01% 340
2014
Q4
$30.4K Buy
+11,422
New +$28.9K ﹤0.01% 353

Other funds holding ZNGA

Exane Derivatives's ZNGA Position: Q2 2022 in Review

Exane Derivatives sold out of ZYNGA INC. CL A COMMON (ZNGA) in Q2 2022, closing a stake of 5,065 shares — an estimated $46.8K sold.

Exane Derivatives first reported a position in ZNGA in Q4 2014 and held it in 22 quarters. The position peaked at $504K in Q2 2020. 3 funds tracked by Wall St. Rank hold ZNGA as of Q2 2022.

  • Exane Derivatives reported no remaining ZYNGA INC. CL A COMMON position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 5,065 ZYNGA INC. CL A COMMON shares in Q2 2022, an estimated $46.8K.
  • Exane Derivatives first reported a position in ZYNGA INC. CL A COMMON in Q4 2014 and held it in 22 quarters.
  • Exane Derivatives's ZYNGA INC. CL A COMMON position peaked at $504K in Q2 2020.
  • 3 funds tracked by Wall St. Rank held ZYNGA INC. CL A COMMON as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.